Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...

Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

Pluristyx makes and sells PluriBank™ iPSC lines as part of their tools, technologies, and services to support the development of cellular therapies, and is currently performing gene editing of ...

While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness.

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient“whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets or ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...